Pfizer Inc. Price — Chart — Historical Data
27.97
-0.1000 (-0.36%)
PFE
| %Chg | Weekly | Monthly | YTD | YoY | |
|---|---|---|---|---|---|
| Pfizer Inc. | -0.36% | 2.64% | 13.98% | 11.08% | 11.26% |
Latest Pfizer Inc. News
Pfizer Stock: Wall Street Sees a Rebound, Here's Our Price Target ↗
Our 24/7 Wall St. price target for Pfizer (NYSE:PFE | PFE Price Prediction) points to $32.36 over the next 12 months, implying 15.27% upside from the…
24/7 Wall Street · Aug 24, 11:00 UTC
Advisors Capital Management LLC Purchases 73,540 Shares of Pfizer Inc. $PFE ↗
Advisors Capital Management LLC raised its holdings in shares of Pfizer Inc. (NYSE: PFE) by 2.8% in the second quarter, according to its most recent…
Defense World · Aug 24, 05:01 UTC
Danske Bank A S Purchases 309,400 Shares of Pfizer Inc. $PFE ↗
Danske Bank A S boosted its position in Pfizer Inc. (NYSE: PFE) by 9.2% during the second quarter, according to the company in its most recent 13F…
Defense World · Aug 23, 04:53 UTC
Danske Bank A S Purchases 309,400 Shares of Pfizer Inc. $PFE ↗
Danske Bank A S boosted its position in Pfizer Inc. (NYSE: PFE) by 9.2% during the second quarter, according to the company in its most recent 13F…
Defense World · Aug 23, 04:20 UTC
Edmond DE Rothschild Holding S.A. Sells 128,428 Shares of Pfizer Inc. $PFE ↗
Edmond DE Rothschild Holding S.A. reduced its position in Pfizer Inc. (NYSE: PFE) by 8.1% in the undefined quarter, according to its most recent…
Defense World · Aug 23, 04:20 UTC
BlackRock Inc. Buys 31,412,883 Shares of Pfizer Inc. $PFE ↗
BlackRock Inc. raised its stake in Pfizer Inc. (NYSE: PFE) by 6.3% during the second quarter, according to the company in its most recent Form 13F…
Defense World · Aug 22, 06:45 UTC
Related
| Related | Price | %Chg |
|---|---|---|
| AbbVie Inc. | 264.52 | -0.17% |
| Abbott Laboratories | 116.67 | 0.03% |
| Amgen Inc. | 443.84 | 1.03% |
| Cigna Corporation | 280.45 | 1.06% |
| Danaher Corporation | 215.20 | -1.67% |
| Elevance Health Inc. | 402.63 | 0.52% |
| Eli Lilly and Company | 1,247.9 | -0.60% |
| Gilead Sciences, Inc. | 146.74 | 0.42% |